Get the Stockscreener App
0.9822
5.65%
-0.0578
Intercure Ltd stock is traded at $0.9822, with a volume of 99,914.
It is down -5.65% in the last 24 hours and down -27.85% over the past month.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
See More
Previous Close:
$1.04
Open:
$1.02
24h Volume:
99,914
Relative Volume:
1.46
Market Cap:
$53.76M
Revenue:
$118.18M
Net Income/Loss:
$5.99M
P/E Ratio:
7.4466
EPS:
0.1319
Net Cash Flow:
$-12.91M
1W Performance:
-1.19%
1M Performance:
-27.85%
6M Performance:
-37.10%
1Y Performance:
-41.25%
1-Day Range:
$0.9756
$1.04
1-Week Range:
$0.68
$1.08
52-Week Range:
$0.68
$1.7799
Intercure Ltd Stock (INCR) Company Profile
Compare INCR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INCR
Intercure Ltd
|
0.9832 | 56.87M | 118.18M | 5.99M | -12.91M | 0.1319 |
|
ZTS
Zoetis Inc
|
129.56 | 57.01B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.78 | 49.57B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.26 | 45.02B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.12 | 35.57B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
503.08 | 21.08B | 3.08B | 1.24B | 1.07B | 25.61 |
Intercure Ltd Stock (INCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-18-22 | Upgrade | Canaccord Genuity | Speculative Buy → Buy |
Intercure Ltd Stock (INCR) Latest News
Top Cannabis Stocks To Watch TodayJanuary 1st - MarketBeat
Top Cannabis Stocks To Watch Today – January 1st - Defense World
Wall Street Recap: How InterCure Ltd stock compares to market leadersJuly 2025 Technicals & Stepwise Swing Trade Plans - moha.gov.vn
InterCure (NASDAQ:INCR) Shares Down 6.6% – Should You Sell? - Defense World
InterCure Shareholders Approve All Proposals at 2025 Annual Meeting - TipRanks
InterCure shareholders approve all proposals at 2025 annual meeting - MSN
We Discuss Why InterCure Ltd.'s (TLV:INCR) CEO Compensation May Be Closely Reviewed - simplywall.st
Why InterCure Ltd. stock could see breakout soonInterest Rate Changes & Zero-Cost Stock Research by Professionals - bollywoodhelpline.com
Will InterCure Ltd. stock gain from strong economyMarket Sentiment Extremes & Exceptional Profit Portfolio - bollywoodhelpline.com
Critical Contrast: InterCure (NASDAQ:INCR) & Varex Imaging (NASDAQ:VREX) - Defense World
Is InterCure Ltd. stock a buy for dividend growthJuly 2025 Volume & Verified Stock Trade Ideas - Улправда
How InterCure Ltd. stock compares to market leaders2025 Earnings Surprises & Fast Gaining Stock Strategy Reports - DonanımHaber
Will InterCure Ltd. stock gain from lower inflationDollar Strength & Weekly Market Pulse Updates - DonanımHaber
What valuation multiples suggest for InterCure Ltd. stockEarnings Growth Report & Technical Confirmation Alerts - ulpravda.ru
InterCure Ltd on Dec 15, became aware that Bazelet Group of Companies has initiated Restructuring proceedings before the Israeli district court - marketscreener.com
InterCure Ltd On Dec 15, Became Aware That Bazelet Group Of Companies Has Initiated Restructuring Proceedings Before The Israeli District Court - TradingView — Track All Markets
InterCure Faces NIS 27 Million Exposure as Key Cannabis Partner Bazelet Enters Restructuring - TipRanks
[6-K] Intercure Ltd. Current Report (Foreign Issuer) | INCR SEC FilingForm 6-K - Stock Titan
InterCure (TLV:INCR) shareholders are up 16% this past week, but still in the red over the last five years - simplywall.st
InterCure May Be Uniquely Positioned as Trump’s Cannabis Rescheduling Returns to Headlines (NASDAQ: INCR) - TradingView — Track All Markets
Head to Head Comparison: InterCure (NASDAQ:INCR) and Jushi (OTCMKTS:JUSHF) - Defense World
How interest rate cuts could boost InterCure Ltd. stockJuly 2025 Fed Impact & Community Verified Trade Signals - Newser
How resilient is InterCure Ltd. stock in market downturnsGold Moves & Expert Approved Trade Ideas - Newser
Is InterCure Ltd. stock a buy before product launchesJuly 2025 Decliners & Weekly Top Performers Watchlists - Newser
Will InterCure Ltd. stock see PE expansionGold Moves & Low Drawdown Trading Strategies - Newser
Why InterCure Ltd. stock appeals to dividend seekersTrade Exit Summary & Verified Entry Point Signals - Newser
US Market Wrap: Can InterCure Ltd. stock deliver sustainable ROEJuly 2025 Intraday Action & Weekly Setup with ROI Potential - BỘ NỘI VỤ
Intercure schedules annual shareholder meeting for December 30 in Tel Aviv - Investing.com Nigeria
InterCure Ltd. Schedules Annual General Meeting for December 2025 - TipRanks
Intercure schedules annual shareholder meeting for December 30 in Tel Aviv By Investing.com - Investing.com South Africa
InterCure (NASDAQ:INCR) Shares Up 0.7% – Time to Buy? - Defense World
How InterCure Ltd. stock performs during Fed tightening cyclesWeekly Trading Summary & High Accuracy Trade Alerts - newser.com
Why InterCure Ltd. stock remains undervaluedJuly 2025 Market Mood & Momentum Based Trading Ideas - newser.com
How InterCure Ltd. stock performs in weak economyMarket Activity Recap & Accurate Intraday Trading Signals - newser.com
Can InterCure Ltd. stock beat market expectations this quarterJuly 2025 EndofMonth & Fast Momentum Entry Tips - newser.com
Is it time to cut losses on InterCure Ltd.Earnings Growth Report & Weekly Breakout Stock Alerts - newser.com
Is InterCure Ltd. stock a buy in volatile marketsIndex Update & Advanced Swing Trade Entry Plans - newser.com
How strong is InterCure Ltd. stock revenue growthJuly 2025 Setups & Daily Stock Trend Watchlist - newser.com
Is InterCure Ltd. stock cheap at current valuationJuly 2025 Decliners & Weekly Top Performers Watchlists - newser.com
Will InterCure Ltd. stock recover after recent dropWeekly Trend Summary & Risk Controlled Daily Trade Plans - newser.com
Does InterCure Ltd. stock trade at a discount to peersLayoff News & Long-Term Growth Stock Strategies - newser.com
Will InterCure Ltd. stock sustain high P E ratiosJuly 2025 Review & Technical Analysis for Trade Confirmation - newser.com
Will InterCure Ltd. stock outperform international peersJuly 2025 Analyst Calls & Scalable Portfolio Growth Ideas - newser.com
Intercure Ltd Stock (INCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):